Zynerba Pharmaceuticals (ZYNE) Q2 2023 Earnings

14AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.22
-0.21
-0.19
-0.18

Details

Expected EPS
-0.2
Actual EPS
-0.21
Surprise EPS
-0.01
Surprise Percent
+5%

Description

Zynerba Pharmaceuticals (ZYNE) has reported earnings of -0.21 per share for Q2 2023.

0 Comments

Share your thoughts